Table 6 |
|||
|
Ferric reducing ability of plasma (FRAP) before (evening) and after (morning) polysomnography controlled sleep |
|||
|
Patients group |
FRAP [μM] measured at |
Diff, 95% CI |
|
|
|
|||
|
Evening |
Morning |
||
|
|
|||
|
OSAS, n = 27 |
671 ± 221 |
602 ± 202 |
70 (7–133) |
|
|
|||
|
Severe OSAS, n = 11 |
729 ± 156 |
650 ± 170 |
79 (37–122) |
|
|
|||
|
CPAP-OSAS, n = 22 |
597 ± 199 |
591 ± 242 |
7 (-44–57) |
|
|
|||
|
Controls, n = 11 |
634 ± 229 |
597 ± 201 |
37 (-3–77) |
|
|
|||
|
OSAS – patients with the untreated OSAS; CPAP-OSAS – patients with OSAS treated successfully after a first attempt with CPAP, controls – subjects without OSAS. Results expressed as a mean ± SD represent concentration of Fe3+ reduced ions after 3 min. incubation of plasma sample with the FRAP reagent. Diff, 95% CI – difference of means with 95% confidence interval No significant differences (p > 0.05) were found for evening and morning FRAP within and between the studied groups. |
|||
|
Grabska-Kobylecka et al. Journal of Negative Results in BioMedicine 2008 7:10 doi:10.1186/1477-5751-7-10 |
|||
